SCHEMBL2496712

SCHEMBL2496712

O=C1Nc2ccc(F)cc2C1(O)c1cccc2c1OCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 4/20 0.44
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.38
BRD4 O60885 3/20 0.38
USP2 O75604 1/20 0.38
F2 P00734 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
POLB P06746 1/20 0.37
CASP6 P55212 1/20 0.37
MAPK14 Q16539 1/20 0.37
SCN9A Q15858 1/20 0.36
MTOR P42345 1/20 0.36
RICTOR Q6R327 1/20 0.36
RPTOR Q8N122 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492740 0.86 IDO1 (0.41) SMN1; SMN2KMT2AALDH1A1MEN1BRD4
SCHEMBL2496973 0.86 L3MBTL1 (0.52) SMN1; SMN2KMT2AMAPTCYP2C19NPSR1
SCHEMBL2492868 0.86 ALDH1A1 (0.53) SMN1; SMN2KMT2ACYP1A2MAPTCYP2C19
SCHEMBL2492745 0.86 ALDH1A1 (0.38) SMN1; SMN2KMT2AMAPTALDH1A1MEN1
SCHEMBL2496902 0.83 PGR (0.40) SMN1; SMN2KMT2AMAPTNPSR1ALDH1A1
SCHEMBL2497599 0.82 MAOB (0.45) SMN1; SMN2KMT2AALDH1A1MEN1USP2
SCHEMBL2501554 0.82 ALPL (0.47) SMN1; SMN2KMT2AMAPTCYP2C19ALDH1A1
SCHEMBL2498220 0.79 MDM2 (0.38) KMT2AMEN1POLBCASP6SCN9A
SCHEMBL2496469 0.77 GSK3B (0.38) HTTKMT2ACYP2C19NPSR1ALDH1A1
SCHEMBL24281000 0.76 HTT (0.50) SMN1; SMN2HTTKMT2ACYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 SMN1; SMN2 2982/4885HTT 6/4885KMT2A 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.